U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H26N4O2
Molecular Weight 354.446
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HEXAMIDINE

SMILES

NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1

InChI

InChIKey=OQLKNTOKMBVBKV-UHFFFAOYSA-N
InChI=1S/C20H26N4O2/c21-19(22)15-5-9-17(10-6-15)25-13-3-1-2-4-14-26-18-11-7-16(8-12-18)20(23)24/h5-12H,1-4,13-14H2,(H3,21,22)(H3,23,24)

HIDE SMILES / InChI
Hexamidine diisethionate has been used in the personal care industry and in a number of over-the-counter (OTC) drug products as an antimicrobial agent. It was shown, that hexamidine diisethionate plays a beneficial role in skin homoeostasis.

Approval Year

PubMed

PubMed

TitleDatePubMed
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.
1990 Apr
Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis.
1990 Jul
1,5-Bis(4-amidinophenoxy)pentane (pentamidine) is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 binding sites.
1998 Jul 17
[Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].
2003
Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report.
2003 Apr
Opportunistic amoebae: challenges in prophylaxis and treatment.
2004 Feb
[Contact allergy to antiseptics: 75 cases analyzed by the dermato-allergovigilance network (Revidal)].
2005 Dec
Acanthamoeba keratitis during orthokeratology.
2005 Oct
Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage.
2006 Apr
Systemic allergy to topical hexamidine.
2006 Aug 7
A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
2006 Jun
[Clinical tolerance of cutaneous antiseptics in 3,403 patients in France].
2006 Oct
[Towards new antibacterial drugs. Interest of para-guanidinoethylcalix[4]arene].
2006 Oct-Nov
Final report on the safety assessment of Hexamidine and Hexamidine Diisethionate.
2007
[Acanthamoeba keratitis: about the first two Tunisian cases].
2007 Feb
Visual outcome and rehabilitation in a case of bilateral acanthamoeba sclerokeratitis.
2007 Oct
In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria.
2007 Sep
Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor.
2007 Sep
Bilateral acanthamoeba keratitis.
2008 Feb
Understanding metabolic pathways for skin anti-aging.
2009 Jul
Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.
2009 May
Painless Acanthamoeba keratitis in a soft contact lens wearer--case report.
2009 Sep
[Infectious keratitis and cosmetic lenses: a five-case retrospective study].
2010 Apr
[Effect of psychotropic drugs on activity of anticonvulsants in maximal electroshock test].
2010 Aug
Action potential-enhanced ATP release from taste cells through hemichannels.
2010 Aug
Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus 229E.
2010 Dec
[Acanthamoeba keratitis. Report of 3 cases diagnosed in central Tunisia].
2010 Feb
Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
2010 Jan
Patents

Patents

Name Type Language
HEXAMIDINE
INCI   INN   MI   WHO-DD  
INCI   INN  
Official Name English
HEXAMIDINE [MI]
Common Name English
Hexamidine [WHO-DD]
Common Name English
HEXAMIDINE [INCI]
Common Name English
hexamidine [INN]
Common Name English
Classification Tree Code System Code
WHO-ATC R02AA18
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-VATC QD08AC04
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
NCI_THESAURUS C258
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-VATC QS01AX08
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-VATC QR01AX07
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-ATC D08AC04
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-VATC QR02AA18
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-VATC QS03AA05
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-ATC S01AX08
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-VATC QD08AC54
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-ATC S03AA05
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
WHO-ATC R01AX07
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
Code System Code Type Description
FDA UNII
3483C2H13H
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
CHEBI
87184
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
CAS
3811-75-4
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
MESH
C018961
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
WIKIPEDIA
HEXAMIDINE
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
MERCK INDEX
m6000
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY Merck Index
DRUG BANK
DB03808
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
INN
1393
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
DRUG CENTRAL
3275
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
EVMPD
SUB08029MIG
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
ChEMBL
CHEMBL25105
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
EPA CompTox
DTXSID60191524
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
SMS_ID
100000083975
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
RXCUI
26849
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY RxNorm
PUBCHEM
65130
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY
NCI_THESAURUS
C65849
Created by admin on Fri Dec 15 16:37:07 UTC 2023 , Edited by admin on Fri Dec 15 16:37:07 UTC 2023
PRIMARY